NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer
NSABP FB-10:一项评估ado-trastuzumab emtansine (T-DM1)联合neratinib治疗HER2阳性转移性乳腺癌女性患者的Ib/II期临床试验
期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-024-01823-8
Jacobs, Samuel A; Wang, Ying; Abraham, Jame; Feng, Huichen; Montero, Alberto J; Lipchik, Corey; Finnigan, Melanie; Jankowitz, Rachel C; Salkeni, Mohamad A; Maley, Sai K; Puhalla, Shannon L; Piette, Fanny; Quinn, Katie; Chang, Kyle; Nagy, Rebecca J; Allegra, Carmen J; Vehec, Kelly; Wolmark, Norman; Lucas, Peter C; Srinivasan, Ashok; Pogue-Geile, Katherine L